Literature DB >> 14258844

MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.

E NORRBY, R LAGERCRANTZ, S GARD.   

Abstract

Keywords:  COMPLEMENT FIXATION TESTS; ETHYL ETHER; HEMAGGLUTINATION INHIBITION TESTS; INFANT; MEASLES; MEASLES VACCINE; NEUTRALIZATION TESTS; STATISTICS; SURFACE-ACTIVE AGENTS; SWEDEN; VACCINATION; VIRUS CULTIVATION

Mesh:

Substances:

Year:  1965        PMID: 14258844      PMCID: PMC2166272     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  EPIDEMIOLOGIC STUDY OF INACTIVATED MEASLES VACCINE.

Authors:  H S MEDOFF; A R HUNT; F E KARPINSKI; S SALITSKY; J E WHEELER
Journal:  JAMA       Date:  1964-09-07       Impact factor: 56.272

2.  MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.

Authors:  E NORRBY; R LAGERCRANTZ; S GARD; G CARLSTROEM
Journal:  Arch Gesamte Virusforsch       Date:  1963-08-26

3.  MEASLES EXPOSURE AMONG VACCINE RECIPIENTS. RESPONSE TO MEASLES EXPOSURE AND ANTIBODY PERSISTENCE AMONG RECIPIENTS OF MEASLES VACCINES.

Authors:  V A FULGINITI; C H KEMPE
Journal:  Am J Dis Child       Date:  1963-11

4.  CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES.

Authors:  C M MARTIN; S J MANFREDONIA; N C WEBB; F S MARKHAM; J M RUEGSEGGER
Journal:  Am J Dis Child       Date:  1963-09

5.  Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.

Authors:  J STOKES; M R HILLEMAN; R E WEIBEL; E B BUYNAK; R HALENDA
Journal:  N Engl J Med       Date:  1962-08-02       Impact factor: 91.245

6.  Immunologic studies of measles.

Authors:  J STOKES; C M REILLY; E B BUYNAK; M R HILLEMAN
Journal:  Am J Hyg       Date:  1961-11

7.  Evaluation of measles immunization methos.

Authors:  V A FULGINITI; O S LELAND; C H KEMPE
Journal:  Am J Dis Child       Date:  1963-01

8.  Serologic response of children to in-activated measles vaccine.

Authors:  C H CARTER; T J CONWAY; D CORNFELD; D G IEZZONI; C H KEMPE; C MOSCOVICI; L W RAUH; A J VIGNEC; J WARREN
Journal:  JAMA       Date:  1962-03-17       Impact factor: 56.272

9.  The gamma globulins.

Authors:  D GITLIN; C A JANEWAY
Journal:  Adv Pediatr       Date:  1957

10.  Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.

Authors:  H A FELDMAN; A NOVACK; J WARREN
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272

View more
  6 in total

1.  Measles vaccination before the measles-mumps-rubella vaccine.

Authors:  Jan Hendriks; Stuart Blume
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  Large-scale purification of rubella virus and preparation of an experimental split rubella virus vaccine.

Authors:  P Väänänen; A Vaheri
Journal:  Appl Microbiol       Date:  1971-09

3.  Inactivated measles virus vaccine. I. Stability of vaccine prepared in chick embryo tissue cultures.

Authors:  L J Lewis; F Pancic; E Winnicki; D C Carpentier
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  Vaccination against measles.

Authors: 
Journal:  Br Med J       Date:  1966-02-19

5.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Evidence and policymaking: The introduction of MMR vaccine in the Netherlands.

Authors:  Stuart Blume; Janneke Tump
Journal:  Soc Sci Med       Date:  2010-07-13       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.